These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 5924745

  • 1. Radiation dose fractionation and tumor control probability.
    Suit H, Wette R.
    Radiat Res; 1966 Oct; 29(2):267-81. PubMed ID: 5924745
    [No Abstract] [Full Text] [Related]

  • 2. Theoretical considerations on the influence of dose fractionation on effectiveness of radiation therapy.
    Suit HD, Wette R.
    Natl Cancer Inst Monogr; 1967 Feb; 24():225-47. PubMed ID: 6021078
    [No Abstract] [Full Text] [Related]

  • 3. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H, Kastelan A.
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract] [Full Text] [Related]

  • 4. Tumor control and pulmonary metastasis in fractionally irradiated transplanted mammary carcinoma in C3H mice.
    Seydel HG, Sloan KW, McCready W.
    J Natl Cancer Inst; 1972 Feb; 48(2):357-62. PubMed ID: 4568965
    [No Abstract] [Full Text] [Related]

  • 5. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma.
    Urano M, Suit HD.
    Radiat Res; 1971 Jan; 45(1):41-9. PubMed ID: 5099671
    [No Abstract] [Full Text] [Related]

  • 6. Proceedings: Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.
    Fowler JF, Denekamp J, Sheldon PW, Smith AM, Begg AC, Harris SR, Page AL.
    Br J Radiol; 1974 Jun; 47(558):365. PubMed ID: 4835220
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Redistribution and reoxygenation in a C 3 H mouse mammary carcinoma.
    Gillette EL, Suit HD, Marshall N.
    Radiat Res; 1972 Jun; 50(3):574-82. PubMed ID: 5030085
    [No Abstract] [Full Text] [Related]

  • 14. Results of fractionation and protraction of total-body radiation on rat mammary neoplasia.
    Shellabarger CJ, Bond VP, Aponte GE, Cronkite EP.
    Cancer Res; 1966 Mar; 26(3):509-13. PubMed ID: 5930698
    [No Abstract] [Full Text] [Related]

  • 15. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S.
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.